Becton Dickinson (BDX) Share-based Compensation (2009 - 2026)
Becton Dickinson's (BDX) quarterly Share-based Compensation came in at $58.0 million in Q1 2026, up 41.46% year-on-year from $41.0 million in Q1 2025, and down 36.26% on a QoQ basis from $91.0 million in Q4 2025.
Becton Dickinson (BDX) Share-based Compensation (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Share-based Compensation data on file, last reported at $58.0 million in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 41.46% year-over-year to $58.0 million in Q1 2026; TTM through Mar 2026 was $276.0 million, a 17.45% increase from a year earlier, with the FY2025 full-year figure at $258.0 million, up 4.45% from the prior year.
- Share-based Compensation for Q1 2026 stood at $58.0 million, down from $91.0 million in the prior quarter.
- Over the last five years, Share-based Compensation for BDX reached as high as $91.0 million in Q4 2025 and fell as low as $41.0 million in Q1 2025.
- Historically, Share-based Compensation has averaged $62.6 million across 5 years, with a median of $56.0 million in 2023.
- Across the five-year window, Share-based Compensation tumbled 31.67% in 2025 and jumped 41.46% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $89.0 million in 2022, then slipped by 6.74% to $83.0 million in 2023, then rose by 8.43% to $90.0 million in 2024, then gained by 1.11% to $91.0 million in 2025, then plunged by 36.26% to $58.0 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $58.0 million in Q1 2026, $91.0 million in Q4 2025, and $55.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.00 Mn |
| Mar 31, 2026 | 58.00 Mn |
| Dec 31, 2025 | 91.00 Mn |
| Dec 31, 2025 | 91.00 Mn |
| Sep 30, 2025 | 55.00 Mn |
| Sep 30, 2025 | 55.00 Mn |
| Jun 30, 2025 | 72.00 Mn |
| Jun 30, 2025 | 72.00 Mn |
| Mar 31, 2025 | 41.00 Mn |
| Mar 31, 2025 | 41.00 Mn |
| Dec 31, 2024 | 90.00 Mn |
| Dec 31, 2024 | 90.00 Mn |
| Sep 30, 2024 | 51.00 Mn |
| Sep 30, 2024 | 51.00 Mn |
| Jun 30, 2024 | 53.00 Mn |
| Jun 30, 2024 | 53.00 Mn |
| Mar 31, 2024 | 60.00 Mn |
| Mar 31, 2024 | 60.00 Mn |
| Dec 31, 2023 | 83.00 Mn |
| Dec 31, 2023 | 83.00 Mn |